Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8136350 | 8405429 | F | 8136350-5 | 20120112 | 20120209 | 20120214 | EXP | SK-BRISTOL-MYERS SQUIBB COMPANY-16389249 | BRISTOL-MYERS SQUIBB COMPANY | 46 | YR | M | Y | 20120214 | MD | SLOVAKIA (Slovak Republic) |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8136350 | 1018860585 | SS | YERVOY | 1 | 2ND DOSE: 14DEC11. FORM:YERVOY 5MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||
| 8136350 | 1018860586 | SS | YERVOY | 1 | 2ND DOSE: 14DEC11. FORM:YERVOY 5MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||
| 8136350 | 1018860584 | PS | YERVOY | 1 | 2ND DOSE: 14DEC11. FORM:YERVOY 5MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8136350 | 1018860585 | METASTASES TO LUNG |
| 8136350 | 1018860586 | METASTASES TO LIVER |
| 8136350 | 1018860584 | RENAL CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8136350 | OT |
| 8136350 | DE |
| 8136350 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8136350 | RESPIRATORY FAILURE |
| 8136350 | HYPOPHYSITIS |
| 8136350 | HEPATIC FAILURE |
| 8136350 | OFF LABEL USE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8136350 | 1018860585 | 20111123 | |||
| 8136350 | 1018860586 | 20111123 | |||
| 8136350 | 1018860584 | 20111123 |